Phase 2 study of danicopan in patients with paroxysmal nocturnal hemoglobinuria with an inadequate response to eculizumab
- Austin G. Kulasekararaj
- , Antonio M. Risitano
- , Jaroslaw P. Maciejewski
- , Rosario Notaro
- , Peter Browett
- , Jong Wook Lee
- , Mingjun Huang
- , Michael Geffner
- , Robert A. Brodsky
- King's College Hospital NHS Foundation Trust
- King's College London
- University of Naples Federico II
- AORN Moscati
- Cleveland Clinic Foundation
- Azienda Ospedaliera Careggi
- la Prevenzione e la Rete Oncologica
- The University of Auckland
- Alexion Pharmaceuticals, Inc.
- Inc.
- Johns Hopkins University
Research output: Contribution to journal › Article › peer-review
70
Scopus
citations